Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections.
Hameed P S, Kotakonda H, Sharma S, Nandishaiah R, Katagihallimath N, Rao R, Sadler C, Slater I, Morton M, Chandrasekaran A, Griffen E, Pillai D, Reddy S, Bharatham N, Venkatesan S, Jonnalagadda V, Jayaraman R, Nanjundappa M, Sharma M, Raveendran S, Rajagopal S, Tumma H, Watters A, Becker H, Lindley J, Flamm R, Huband M, Sahm D, Hackel M, Mathur T, Kolamunnage-Dona R, Unsworth J, Mcentee L, Farrington N, Manickam D, Chandrashekara N, Jayachandiran S, Reddy H, Shanker S, Richard V, Thomas T, Nagaraj S, Datta S, Sambandamurthy V, Ramachandran V, Clay R, Tomayko J, Das S, V B. Hameed P S, et al. Among authors: mcentee l. Nat Commun. 2024 Sep 18;15(1):8202. doi: 10.1038/s41467-024-52557-2. Nat Commun. 2024. PMID: 39294149 Free PMC article. Clinical Trial.
Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance.
Farrington N, McEntee L, Johnson A, Unsworth J, Darlow C, Jimenez-Valverde A, Hornik C, Greenberg R, Schwartz J, Das S, Hope W. Farrington N, et al. Among authors: mcentee l. Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0218121. doi: 10.1128/aac.02181-21. Epub 2022 Mar 22. Antimicrob Agents Chemother. 2022. PMID: 35315689 Free PMC article.
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings.
Darlow CA, McEntee L, Johnson A, Farrington N, Unsworth J, Jimenez-Valverde A, Jagota B, Kolamunnage-Dona R, Da Costa RMA, Ellis S, Franceschi F, Sharland M, Neely M, Piddock L, Das S, Hope W. Darlow CA, et al. Among authors: mcentee l. J Antimicrob Chemother. 2022 Nov 28;77(12):3349-3357. doi: 10.1093/jac/dkac323. J Antimicrob Chemother. 2022. PMID: 36177766 Free PMC article.
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
Darlow CA, Farrington N, Johnson A, McEntee L, Unsworth J, Jimenez-Valverde A, Kolamunnage-Dona R, Da Costa RMA, Ellis S, Franceschi F, Sharland M, Neely M, Piddock LJV, Das S, Hope W. Darlow CA, et al. Among authors: mcentee l. J Antimicrob Chemother. 2022 Apr 27;77(5):1334-1343. doi: 10.1093/jac/dkac038. J Antimicrob Chemother. 2022. PMID: 35170719 Free PMC article.
Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae.
Das S, Johnson A, McEntee L, Farrington N, Kirby A, Unsworth J, Jimenez-Valverde A, Kolamunnage-Dona R, Bousquet J, Alibaud L, Sable C, Zalacain M, Everett M, Hope W. Das S, et al. Among authors: mcentee l. Antimicrob Agents Chemother. 2020 Oct 20;64(11):e01076-20. doi: 10.1128/AAC.01076-20. Print 2020 Oct 20. Antimicrob Agents Chemother. 2020. PMID: 32778549 Free PMC article.
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.
Darlow CA, Docobo-Perez F, Farrington N, Johnson A, McEntee L, Unsworth J, Jimenez-Valverde A, Gastine S, Kolamunnage-Dona R, de Costa RMA, Ellis S, Franceschi F, Standing JF, Sharland M, Neely M, Piddock L, Das S, Hope W. Darlow CA, et al. Among authors: mcentee l. Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0029321. doi: 10.1128/AAC.00293-21. Epub 2021 Jun 17. Antimicrob Agents Chemother. 2021. PMID: 33972238 Free PMC article.
Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae.
Johnson A, McEntee L, Farrington N, Kolamunnage-Dona R, Franzoni S, Vezzelli A, Massimiliano M, Knechtle P, Belley A, Dane A, Drusano G, Das S, Hope W. Johnson A, et al. Among authors: mcentee l. Antimicrob Agents Chemother. 2020 May 21;64(6):e00180-20. doi: 10.1128/AAC.00180-20. Print 2020 May 21. Antimicrob Agents Chemother. 2020. PMID: 32253209 Free PMC article.
Pharmacodynamics of teicoplanin against MRSA.
Ramos-Martín V, Johnson A, McEntee L, Farrington N, Padmore K, Cojutti P, Pea F, Neely MN, Hope WW. Ramos-Martín V, et al. Among authors: mcentee l. J Antimicrob Chemother. 2017 Dec 1;72(12):3382-3389. doi: 10.1093/jac/dkx289. J Antimicrob Chemother. 2017. PMID: 28962026
29 results